Italia Markets close in 3 hrs 57 mins

Incyte Corporation (INCY)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
74,22+0,60 (+0,81%)
Alla chiusura: 04:00PM EDT
74,01 -0,21 (-0,28%)
Preborsa: 07:00AM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente73,62
Aperto73,53
Denaro66,92 x 900
Lettera87,50 x 1100
Min-Max giorno72,96 - 74,51
Intervallo di 52 settimane65,07 - 86,29
Volume1.197.475
Media Volume1.617.467
Capitalizzazione16,512B
Beta (5 anni mensile)0,73
Rapporto PE (ttm)N/D
EPS (ttm)-1,36
Prossima data utili01 mag 2023 - 05 mag 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A89,19
  • GlobeNewswire

    Knight Therapeutics Announces Regulatory Submission for Tafasitamab in Brazil

    MONTREAL, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization application for tafasitamab in combination with lenalidomide to ANVISA, the Brazilian health regulatory agency, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for auto